期刊文献+

利拉鲁肽对β细胞的保护和早期获益 被引量:2

Liraglutide protects pancreatic beta cells and its early benefits for type 2 diabetes
下载PDF
导出
摘要 如何有效保护β细胞功能和长期维持血糖控制,是当前糖尿病管理中迫切需要解决的问题。新型降糖药物人GLP-1类似物利拉鲁肽能有效保护和恢复β细胞功能,逆转糖尿病前期进展的作用。本文围绕利拉鲁肽对β细胞的保护作用及2型糖尿病的早期临床获益作一综述。
作者 郭晓蕙
出处 《药品评价》 CAS 2014年第15期38-42,共5页 Drug Evaluation
  • 相关文献

参考文献32

  • 1Chen L, Magliano D J, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives[J]. Nat Rev Endocrinol, 2012, 8(4): 228-236.
  • 2Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: the last ten years[J]. Cell, 2012, 148(6): 1160-1171.
  • 3Buchanan TA. Pancreatic beta-cell loss and preservation in type 2 diabetes[J]. Clin Ther, 2003, 25(Suppl B): B32-46.
  • 4Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes[J]. Diabetologia, 2003, 46(1): 3-19.
  • 5Porte D Jr, Kahn SE. Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms[J]. Diabetes, 2001, 50(Suppl 1): S160-163.
  • 6ADA. Standards of medical care in diabetes-2011 [J]. Diabetes Care, 2011, 34(Suppl I):S11-61.
  • 7Bergman RN. Minimal model: perspective from 2005[J]. Horm Res, 2005, 64(Suppl 3): 8-15.
  • 8Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metforrnin[J]. N Engl J Med, 2002, 346(6): 393-403.
  • 9Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance[J]. N Engl J Med, 2001, 344(18): 1343-1350.
  • 10De Mello VD, Lindstrom J, Eriksson J, et al. Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study[J]. Diabete Care, 2012, 35(2): 211-217.

同被引文献14

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部